Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludovic Lacroix

Showing results (101-110 of 180) with videos related to

Pageof 18
Sort By:
Molecular Cancer|November 6, 2023
Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluidCyril Roussel-Simonin, Felix Blanc-Durand, Roseline Tang, et al.
Plos One|June 12, 2020
Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assayJordi Remon, Aurelie Swalduz, David Planchard, et al.
Clinical Lung Cancer|June 6, 2022
Clinical Utility and Outcomes Impact of Crystal Digital PCR of Sensitizing and Resistance EGFR Mutations in Patients With Advanced Non-Small Cell Lung CancerMariona Riudavets, Virginie Lamberts, Damien Vasseur, et al.
Brain Pathology (Zurich, Switzerland)|December 17, 2016
Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I gangliogliomaMélanie Pagès, Kevin Beccaria, Nathalie Boddaert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLCLuc Friboulet, Daniel Barrios-Gonzales, Frédéric Commo, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2017
Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trialLoic Verlingue, David Malka, Adrien Allorant, et al.
BMC Cancer|February 1, 2015
Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortiumBastiaan B J Tops, Nicola Normanno, Henriette Kurth, et al.
Cancers|December 17, 2020
Chronic Plasma Exposure to Kinase Inhibitors in Patients with Oncogene-Addicted Non-Small Cell Lung CancerArthur Geraud, Laura Mezquita, Edouard Auclin, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2023
Hepatic arterial oxaliplatin plus intravenous 5-fluorouracil and cetuximab for first-line treatment of colorectal liver metastases: A multicenter phase II trialDavid Malka, Benjamin Verret, Matthieu Faron, et al.
European Journal of Cancer (Oxford, England : 1990)|May 11, 2020
Molecular mechanisms of resistance to BRAF and MEK inhibitors in BRAF<sup>V600E</sup> non-small cell lung cancerFrancesco Facchinetti, Ludovic Lacroix, Laura Mezquita, et al.
Pageof 18

Showing results (101-110 of 180) with videos related to

Sort By:
Pageof 18
Molecular Cancer|November 6, 2023
Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluidCyril Roussel-Simonin, Felix Blanc-Durand, Roseline Tang, et al.
Plos One|June 12, 2020
Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assayJordi Remon, Aurelie Swalduz, David Planchard, et al.
Clinical Lung Cancer|June 6, 2022
Clinical Utility and Outcomes Impact of Crystal Digital PCR of Sensitizing and Resistance EGFR Mutations in Patients With Advanced Non-Small Cell Lung CancerMariona Riudavets, Virginie Lamberts, Damien Vasseur, et al.
Brain Pathology (Zurich, Switzerland)|December 17, 2016
Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I gangliogliomaMélanie Pagès, Kevin Beccaria, Nathalie Boddaert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLCLuc Friboulet, Daniel Barrios-Gonzales, Frédéric Commo, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2017
Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trialLoic Verlingue, David Malka, Adrien Allorant, et al.
BMC Cancer|February 1, 2015
Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortiumBastiaan B J Tops, Nicola Normanno, Henriette Kurth, et al.
Cancers|December 17, 2020
Chronic Plasma Exposure to Kinase Inhibitors in Patients with Oncogene-Addicted Non-Small Cell Lung CancerArthur Geraud, Laura Mezquita, Edouard Auclin, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2023
Hepatic arterial oxaliplatin plus intravenous 5-fluorouracil and cetuximab for first-line treatment of colorectal liver metastases: A multicenter phase II trialDavid Malka, Benjamin Verret, Matthieu Faron, et al.
European Journal of Cancer (Oxford, England : 1990)|May 11, 2020
Molecular mechanisms of resistance to BRAF and MEK inhibitors in BRAF<sup>V600E</sup> non-small cell lung cancerFrancesco Facchinetti, Ludovic Lacroix, Laura Mezquita, et al.
Pageof 18